These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32653046)

  • 1. The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals.
    Frenette C; Sperlea D; German GJ; Afra K; Boswell J; Chang S; Goossens H; Grant J; Lefebvre MA; McGeer A; Mertz D; Science M; Versporten A; Thirion DJG
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):104. PubMed ID: 32653046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional survey.
    German GJ; Frenette C; Caissy JA; Grant J; Lefebvre MA; Mertz D; Lutes S; McGeer A; Roberts J; Afra K; Valiquette L; Émond Y; Carrier M; Lauzon-Laurin A; Nguyen TT; Al-Bachari H; Kosar J; Peermohamed S; Science M; Landry D; MacLaggan T; Daley P; McDonald G; Ang A; Chang S; Lin YC; Tong B; Malfair S; Leung V; Katz K; Pauwels I; Goossens H; Versporten A; Conly J; Thirion DJG
    CMAJ Open; 2021; 9(4):E1242-E1251. PubMed ID: 34933882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017.
    Vandael E; Latour K; Goossens H; Magerman K; Drapier N; Catry B; Versporten A;
    Antimicrob Resist Infect Control; 2020; 9(1):13. PubMed ID: 31956402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017.
    Plachouras D; Kärki T; Hansen S; Hopkins S; Lyytikäinen O; Moro ML; Reilly J; Zarb P; Zingg W; Kinross P; Weist K; Monnet DL; Suetens C;
    Euro Surveill; 2018 Nov; 23(46):. PubMed ID: 30458917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children.
    Versporten A; Bielicki J; Drapier N; Sharland M; Goossens H;
    J Antimicrob Chemother; 2016 Apr; 71(4):1106-17. PubMed ID: 26747104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial use in acute care hospitals: national point prevalence survey on healthcare-associated infections and antimicrobial use, Switzerland, 2017.
    Zingg W; Metsini A; Gardiol C; Balmelli C; Behnke M; Troillet N; Widmer A; Pittet D;
    Euro Surveill; 2019 Aug; 24(33):. PubMed ID: 31431211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global point prevalence survey of antimicrobial consumption in Brazilian hospitals.
    Porto APM; Goossens H; Versporten A; Costa SF;
    J Hosp Infect; 2020 Feb; 104(2):165-171. PubMed ID: 31678430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.
    Versporten A; Zarb P; Caniaux I; Gros MF; Drapier N; Miller M; Jarlier V; Nathwani D; Goossens H;
    Lancet Glob Health; 2018 Jun; 6(6):e619-e629. PubMed ID: 29681513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the impact of the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) on hospital antimicrobial stewardship programmes: results of a worldwide survey.
    Pauwels I; Versporten A; Vermeulen H; Vlieghe E; Goossens H
    Antimicrob Resist Infect Control; 2021 Sep; 10(1):138. PubMed ID: 34583775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid use in German acute care hospitals: results from two consecutive national point prevalence surveys.
    Kramer TS; Schwab F; Behnke M; Hansen S; Gastmeier P; Aghdassi SJS
    Antimicrob Resist Infect Control; 2019; 8():159. PubMed ID: 31649816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.
    Korinteli IG; Mchedlishvili I; Javakhadze M; Versporten A; Goossens H; Phagava H; Pagava K
    Georgian Med News; 2019; (292-293):72-75. PubMed ID: 31560667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point prevalence survey of antibiotic use in 26 Saudi hospitals in 2016.
    Al Matar M; Enani M; Binsaleh G; Roushdy H; Alokaili D; Al Bannai A; Khidir Y; Al-Abdely H
    J Infect Public Health; 2019; 12(1):77-82. PubMed ID: 30270148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic Prescriptions and Prophylaxis in Italian Children. Is It Time to Change? Data from the ARPEC Project.
    De Luca M; Donà D; Montagnani C; Lo Vecchio A; Romanengo M; Tagliabue C; Centenari C; D'Argenio P; Lundin R; Giaquinto C; Galli L; Guarino A; Esposito S; Sharland M; Versporten A; Goossens H; Nicolini G
    PLoS One; 2016; 11(5):e0154662. PubMed ID: 27182926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing a baseline for a national paediatric antimicrobial stewardship programme.
    Gibbons CL; Malcolm W; Sneddon J; Doherty C; Cairns S; Milne A; Llano M; Reilly JS
    J Antimicrob Chemother; 2019 Oct; 74(10):3104-3110. PubMed ID: 31299069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare-associated infections and antimicrobial use in acute care hospitals: a point prevalence survey in Lombardy, Italy, in 2022.
    Antonelli A; Ales ME; Chiecca G; Dalla Valle Z; De Ponti E; Cereda D; Crottogini L; Renzi C; Signorelli C; Moro M
    BMC Infect Dis; 2024 Jun; 24(1):632. PubMed ID: 38918691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic prescriptions in Italian hospitalised children after serial point prevalence surveys (or pointless prevalence surveys): has anything actually changed over the years?
    Tersigni C; Montagnani C; D'Argenio P; Duse M; Esposito S; Hsia Y; Sharland M; Galli L
    Ital J Pediatr; 2019 Oct; 45(1):127. PubMed ID: 31623633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK.
    Gharbi M; Doerholt K; Vergnano S; Bielicki JA; Paulus S; Menson E; Riordan A; Lyall H; Patel SV; Bernatoniene J; Versporten A; Heginbothom M; Goossens H; Sharland M;
    BMJ Open; 2016 Nov; 6(11):e012675. PubMed ID: 27810974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
    J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point prevalence surveys of antibiotic prescribing in children at a tertiary hospital in a resource constraint, low-income sub-Saharan African country-the impact of an antimicrobial stewardship program.
    Akintan P; Oshun P; Osuagwu C; Ola-Bello O; Fajolu I; Roberts A; Temiye E; Oduyebo O
    BMC Pediatr; 2024 Jun; 24(1):383. PubMed ID: 38834956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe.
    Zarb P; Goossens H
    Drugs; 2011 Apr; 71(6):745-55. PubMed ID: 21504250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.